Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
115.7 USD | +0.46% | -0.93% | -5.30% |
31/05 | Zimmer Biomet's Limited Exposure to High-Growth Markets Spurs Revenue Concerns, UBS Says | MT |
31/05 | Barclays Adjusts Price Target on Zimmer Biomet to $125 From $130 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.51% | 2.37TCr | |
-6.16% | 18TCr | |
-0.20% | 11TCr | |
-2.31% | 6.7TCr | |
-6.25% | 4.72TCr | |
+11.21% | 4.46TCr | |
+9.25% | 4.25TCr | |
+15.15% | 3TCr | |
+15.97% | 2.52TCr | |
-5.06% | 2.41TCr |
- Stock Market
- Equities
- ZBH Stock
- News Zimmer Biomet Holdings, Inc.
- Argus Upgrades Zimmer Biomet to Buy From Hold With $150 Price Target